Deal Announcements

Interlace Medical Secures New Venture Capital

Wednesday, June 17, 2009 5:56:00 AM PDT | VentureDeal Staff

Framingham, Massachusetts  --  Medical device company Interlace Medical has garnered $20.5 million for its third round of venture capital financing.

Interlace is focused on developing less invasive gynecology procedures that can be performed in an office setting rather than traditional surgical settings.

Baird Venture Partners and HLM Venture Partners led the round, which also included Hambrecht & Quist Capital Management, Aperture Venture Partners, New Leaf Venture Partners and Spray Venture Partners.  The company said that the funding proceeds would be used to begin commercialization of its minimally invasive treatment to remove intrauterine fibroids and polyps.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1